Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Treatment Strategies for p53 Mutant Oral Epithelial Dysplasia and SCC Study

NCT07090070 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT07090070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Treatment Strategies for p53 Mutant Oral Epithelial Dysplasia and SCC Study
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Recruiting
Start date
July 8, 2026
Completion date
September 30, 2032
Enrollment
636 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral epithelial dysplasia (oed), oral squamous cell carcinoma (scc)